Cyclic RGD β-Lactam Peptidomimetics Induce Differential Gene Expression in Human Endothelial Cells

ChemBioChem

Volumn 12, Issue 3, 2011, Pages 401-405

  Aizpurua, Jesus M ^a   Ganboa, José Ignacio ^a   Palomo, Claudio ^a   Loinaz, Iraida ^a   Oyarbide, Joseba ^a   Fernandez, Xabier ^a   Balentová, Eva ^a   Fratila, Raluca M ^a   Jiménez, Azucena ^a   Miranda, José Ignacio ^a   Laso, Antonio ^b   Ávila, Silvia ^b   Castrillo, José Luis ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Genetadi Biotech   (Spain)

Author keywords

Antitumor agents; Cell adhesion; Gene expression; Peptides; Peptidomimetics

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BETA LACTAM DERIVATIVE; PEPTIDE DERIVATIVE; PEPTIDOMIMETIC AGENT;

ARTICLE; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION; GENE INDUCTION; HUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN ALPHAVBETA3; LACTAMS; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES, CYCLIC; PEPTIDOMIMETICS; SIGNAL TRANSDUCTION;

EID: 79551552691     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.201000572     Document Type: Article

References (32)

1. R. Haubner, W. Schmitt, G. Hölzemann, S. L. Goodman, A. Jonczyk, H. Kessler, J. Am. Chem. Soc. 1996, 118, 7881-7891;
2. L. Belvisi, A. Bernardi, A. Checchia, L. Manzoni, D. Potenza, C. Scolastico, M. Castorina, A. Cupelli, G. Giannini, P. Carminati, C. Pisano, Org. Lett. 2001, 3, 1001-1004;
3. S. Urman, K. Gaus, Y. Yang, U. Strijowski, N. Sewald, S. De Pol, O. Reiser, Angew. Chem. 2007, 119, 4050-4053; Angew. Chem. Int. Ed. 2007, 46, 3976-3978;
4. A. S. M. da Ressurreicao, A. Vidu, M. Civera, L. Belvisi, D. Potenza, L. Manzoni, S. Ongeri, C. Gennari, U. Piarulli, Chem. Eur. J. 2009, 15, 12184-12188.
5. J.-P. Xiong, T. Stehle, R. Zhang, A. Joachimiak, M. Frech, S. L. Goodman, M. A. Arnaout, Science 2002, 296, 151-155;
6. L. Marinelli, A. Lavechia, K. E. Gottschalk, E. Novellino, H. Kessler, J. Med. Chem. 2003, 46, 4393-4404;
7. D. Craig, M. Gao, K. Schulten, V. Vogel, Structure 2004, 12, 2049-2058;
8. T. Cupido, J. Spengler, J. Ruiz-Rodriguez, J. Adan, F. Mitjans, J. Piulats, F. Albericio, Angew. Chem. 2010, 122, 2792-2797; Angew. Chem. Int. Ed. 2010, 49, 2732-2737.
9. For a genetic and cell biological analysis of integrin outside-in signaling see: K. R. Legate, S. A. Wickström, R. Fässler, Genes Dev. 2009, 23, 397-418.
10. For a recent review on the resistance to anti-angiogenic therapies, see: Y. Crawford, N. Ferrara, Trends Pharmacol. Sci. 2009, 30, 624-630.
11. T. Kume, Trends Cardiovasc. Med. 2008, 18, 224-228.
12. S. P. Ivy, J. Y. Wick, B. M. Kaufman, Nat. Rev. Clin. Oncol. 2009, 6, 569-579.
13. C. Clapp, S. Thebault, M. C. Jeziorski, G. Martinez De La Escalera, Physiol. Rev. 2009, 89, 1177-1215.
14. C. Gilon, C. Mang, E. Lohof, A. Friedler, H. Kessler in Houben-Weyl Methods of Organic Chemistry, Vol. E22b: Synthesis of Peptides and Peptidomimetics (Eds.: M. Goodman, A. Felix, L. Moroder, C. Toniolo) Thieme, Stuttgart, 2003, pp. 461-542;
15. M. Gurrath, G. Müller, H. Kessler, M. Aumailley, R. Timpl, Eur. J. Biochem. 1992, 210, 911-921.
16. R. M. Freidinger, D. F. Veber, D. S. Perlow, J. R. Brooks, R. Saperstein, Science 1980, 210, 656;
17. R. M. Freidinger, J. Med. Chem. 2003, 46, 5553-5566.
18. G. V. Nikiforovich, K. E. Kövér, W.-J. Zhang, G. R. Marshall, J. Am. Chem. Soc. 2000, 122, 3262-3273.
19. M. A. Dechantsreiter, E. Planker, B. Mathä, E. Lohof, G. Hölzemann, A. Jonczyk, S. L. Goodman, H. Kessler, J. Med. Chem. 1999, 42, 3033-3040.
20. C. Palomo, J. M. Aizpurua, A. Benito, J. I. Miranda, R. M. Fratila, C. Matute, M. Domercq, F. Gago, S. Martin-Santamaria, A. Linden, J. Am. Chem. Soc. 2003, 125, 16243-16260.
21. C. Palomo, J. M. Aizpurua, E. Balentova, A. Jimenez, J. Oyarbide, R. M. Fratila, J. I. Miranda, Org. Lett. 2008, 10, 101-104.
22. J. M. Beierle, W. S. Horne, J. H. van Maarseveen, B. Waser, J. C. Reubi, M. R. Ghadiri, Angew. Chem. 2009, 121, 4819-4823; Angew. Chem. Int. Ed. 2009, 48, 4725-4729.
23. For a review on conformation-directed macrocyclizations, see: J. Blankenstein, J. Zhu, Eur. J. Org. Chem. 2005, 1949-1964.
24. M. Kawaguchi, R. Hosotani, S. Ohishi, N. Fujii, S. S. Tulachan, M. Koizumi, E. Toyoda, T. Masui, S. Nakajima, S. Tsuji, J. Ida, K. Fujimoto, M. Wada, R. Doi, M. Imamura, Biochem. Biophys. Res. Commun. 2001, 288, 711-717.
25. R. Haubner, D. Finsinger, H. Kessler, Angew. Chem. 1997, 109, 1440-1456; Angew. Chem. Int. Ed. Engl. 1997, 36, 1374-1389.
26. Three additional diastereomers of compound 4a were prepared, their conformations in water were studied, and their binding abilities were tested: see pages S20-S21 in the Supporting Information.
27. S. Kostidis, A. Stavrakoudis, N. Biris, D. Tsoukatos, C. Sakarellos, V. Tsikaris, J. Pept. Sci. 2004, 10, 494-509;
28. M. Salvati, F. M. Cordero, F. Pisaneschi, F. Melani, P. Gratteri, N. Cini, A. Bottoncetti, A. Brandi, Bioorg. Med. Chem. 2008, 16, 4262-4271. See also ref. [2d].
29. N. G. Costouros, S. K. Libutti, Expert Opin. Biol. Ther. 2002, 2, 545-556.
30. For an example of pro-angiogenic behavior of RGD-mimetic integrin inhibitors, see: A. R. Reynolds, I. R. Hart, A. R. Watson, J. C. Weiti, R. G. Silva, S. D. Robinson, G. Da Violante, M. Gourlaouen, M. Salih, M. C. Jones, D. T. Jones, G. Saunders, V. Kostourou, F. Perron-Sierra, J. C. Norman, G. C. Tucker, K. M. Hodivala-Dilke, Nat. Med. 2009, 15, 392-400.
31. M. Tomomura, N. Morita, F. Yoshikawa, A. Konishi, H. Akiyama, T. Furuichi, H. Kamiguchi, Neuroscience 2007, 148, 510-521.
32. J. Ding, Z. Zhang, G. J. Roberts, M. Falcone, Y. Miao, Y. Shao, X. C. Zhang, D. W. Andrews, J. Lin, J. Biol. Chem. 2010, 285, 28749-28763.